| UniProt ID | ZCH14_HUMAN | |
|---|---|---|
| UniProt AC | Q8WYQ9 | |
| Protein Name | Zinc finger CCHC domain-containing protein 14 | |
| Gene Name | ZCCHC14 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 949 | |
| Subcellular Localization | ||
| Protein Description | ||
| Protein Sequence | MASNHPAFSFHQKQVLRQELTQIQSSLNGGGGHGGKGAPGPGGALPTCPACHKITPRTEAPVSSVSNSLENALHTSAHSTEESLPKRPLGKHSKVSVEKIDLKGLSHTKNDRNVECSFEVLWSDSSITSVTKSSSEVTEFISKLCQLYPEENLEKLIPCLAGPDAFYVERNHVDLDSGLRYLASLPSHVLKNDHVRRFLSTSSPPQQLQSPSPGNPSLSKVGTVMGVSGRPVCGVAGIPSSQSGAQHHGQHPAGSAAPLPHCSHAGSAGSALAYRTQMDTSPAILMPSSLQTPQTQEQNGILDWLRKLRLHKYYPVFKQLSMEKFLSLTEEDLNKFESLTMGAKKKLKTQLELEKEKSERRCLNPSAPPLVTSSGVARVPPTSHVGPVQSGRGSHAAELRVEVEQPHHQLPREGSSSEYSSSSSSPMGVQAREESSDSAEENDRRVEIHLESSDKEKPVMLLNHFTSSSARPTAQVLPVQNEASSNPSGHHPLPPQMLSAASHITPIRMLNSVHKPERGSADMKLLSSSVHSLLSLEERNKGSGPRSSMKVDKSFGSAMMDVLPASAPHQPVQVLSGLSESSSMSPTVSFGPRTKVVHASTLDRVLKTAQQPALVVETSTAATGTPSTVLHAARPPIKLLLSSSVPADSAISGQTSCPNNVQISVPPAIINPRTALYTANTKVAFSAMSSMPVGPLQGGFCANSNTASPSSHPSTSFANMATLPSCPAPSSSPALSSVPESSFYSSSGGGGSTGNIPASNPNHHHHHHHQQPPAPPQPAPPPPGCIVCTSCGCSGSCGSSGLTVSYANYFQHPFSGPSVFTFPFLPFSPMCSSGYVSAQQYGGGSTFPVVHAPYSSSGTPDPVLSGQSTFAVPPMQNFMAGTAGVYQTQGLVGSSNGSSHKKSGNLSCYNCGATGHRAQDCKQPSMDFNRPGTFRLKYAPPAESLDSTD | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 3 | Phosphorylation | -----MASNHPAFSF -----CCCCCCCCCH | 34.08 | 18187866 | |
| 53 | Ubiquitination | PTCPACHKITPRTEA CCCCCCCCCCCCCCC | 48.43 | 29967540 | |
| 108 | Phosphorylation | DLKGLSHTKNDRNVE ECCCCCCCCCCCCCE | 28.32 | 24719451 | |
| 131 | Phosphorylation | DSSITSVTKSSSEVT CCCCEEEECCHHHHH | 25.61 | - | |
| 135 | Phosphorylation | TSVTKSSSEVTEFIS EEEECCHHHHHHHHH | 43.08 | - | |
| 143 | Ubiquitination | EVTEFISKLCQLYPE HHHHHHHHHHHHCCH | 48.76 | 29967540 | |
| 200 | Phosphorylation | DHVRRFLSTSSPPQQ HHHHHHHCCCCCCHH | 24.43 | 29978859 | |
| 201 | Phosphorylation | HVRRFLSTSSPPQQL HHHHHHCCCCCCHHH | 35.06 | 29978859 | |
| 202 | Phosphorylation | VRRFLSTSSPPQQLQ HHHHHCCCCCCHHHC | 37.15 | 30624053 | |
| 203 | Phosphorylation | RRFLSTSSPPQQLQS HHHHCCCCCCHHHCC | 40.46 | 30624053 | |
| 210 | Phosphorylation | SPPQQLQSPSPGNPS CCCHHHCCCCCCCCC | 35.62 | 25159151 | |
| 212 | Phosphorylation | PQQLQSPSPGNPSLS CHHHCCCCCCCCCHH | 51.16 | 29978859 | |
| 217 | Phosphorylation | SPSPGNPSLSKVGTV CCCCCCCCHHHCCEE | 49.64 | 29978859 | |
| 321 | Phosphorylation | YPVFKQLSMEKFLSL HHHHHHHCHHHHHCC | 23.54 | 19413330 | |
| 324 | Acetylation | FKQLSMEKFLSLTEE HHHHCHHHHHCCCHH | 42.85 | 90773 | |
| 327 | Phosphorylation | LSMEKFLSLTEEDLN HCHHHHHCCCHHHHH | 36.06 | 19413330 | |
| 355 | Acetylation | KTQLELEKEKSERRC HHHHHHHHHHHHHHC | 80.98 | 20167786 | |
| 372 | O-linked_Glycosylation | PSAPPLVTSSGVARV CCCCCCCCCCCCCCC | 25.51 | 28657654 | |
| 394 | Phosphorylation | PVQSGRGSHAAELRV CCCCCCCCCEEEEEE | 14.48 | 28555341 | |
| 415 | Phosphorylation | HQLPREGSSSEYSSS CCCCCCCCCCCCCCC | 26.41 | 27732954 | |
| 416 | Phosphorylation | QLPREGSSSEYSSSS CCCCCCCCCCCCCCC | 37.74 | 27732954 | |
| 417 | Phosphorylation | LPREGSSSEYSSSSS CCCCCCCCCCCCCCC | 42.10 | 27732954 | |
| 420 | Phosphorylation | EGSSSEYSSSSSSPM CCCCCCCCCCCCCCC | 21.49 | 27732954 | |
| 421 | Phosphorylation | GSSSEYSSSSSSPMG CCCCCCCCCCCCCCC | 33.08 | 27732954 | |
| 422 | Phosphorylation | SSSEYSSSSSSPMGV CCCCCCCCCCCCCCC | 28.44 | 27732954 | |
| 423 | Phosphorylation | SSEYSSSSSSPMGVQ CCCCCCCCCCCCCCE | 36.46 | 27732954 | |
| 424 | Phosphorylation | SEYSSSSSSPMGVQA CCCCCCCCCCCCCEE | 40.17 | 27732954 | |
| 425 | Phosphorylation | EYSSSSSSPMGVQAR CCCCCCCCCCCCEEC | 22.36 | 27732954 | |
| 520 | Phosphorylation | VHKPERGSADMKLLS CCCCCCCCCCHHHHH | 27.58 | 23917254 | |
| 548 | Phosphorylation | KGSGPRSSMKVDKSF CCCCCCHHCEECHHH | 24.73 | 27251275 | |
| 595 | Ubiquitination | VSFGPRTKVVHASTL EECCCCCEEEEHHHH | 43.47 | 29967540 | |
| 608 | Phosphorylation | TLDRVLKTAQQPALV HHHHHHHHCCCCEEE | 26.07 | 28348404 | |
| 903 | Phosphorylation | NGSSHKKSGNLSCYN CCCCCCCCCCEEEEC | 37.40 | 24114839 | |
| 914 | Phosphorylation | SCYNCGATGHRAQDC EEECCCCCCCCCCCC | 20.85 | 24114839 | |
| 937 | Ubiquitination | RPGTFRLKYAPPAES CCCEEECEECCCHHH | 34.80 | 29967540 | |
| 948 | Phosphorylation | PAESLDSTD------ CHHHCCCCC------ | 45.45 | 28985074 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of ZCH14_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of ZCH14_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of ZCH14_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
Oops, there are no PPI records of ZCH14_HUMAN !! | ||||
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Phosphorylation | |
| Reference | PubMed |
| "Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-321 AND SER-327, ANDMASS SPECTROMETRY. | |
| "Automated phosphoproteome analysis for cultured cancer cells by two-dimensional nanoLC-MS using a calcined titania/C18 biphasic column."; Imami K., Sugiyama N., Kyono Y., Tomita M., Ishihama Y.; Anal. Sci. 24:161-166(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-3, AND MASSSPECTROMETRY. | |